Asia Pacific Intravenous Immunoglobulin Market Size & Outlook

The intravenous immunoglobulin market in Asia Pacific is expected to reach a projected revenue of US$ 5,201.7 million by 2030. A compound annual growth rate of 8.3% is expected of Asia Pacific intravenous immunoglobulin market from 2024 to 2030.
Revenue, 2023 (US$M)
$2,968.8
Forecast, 2030 (US$M)
$5,201.7
CAGR, 2024 - 2030
8.3%
Report Coverage
Asia Pacific

Asia Pacific intravenous immunoglobulin market, 2018-2030 (US$M)

Asia

Asia Pacific intravenous immunoglobulin market highlights

  • The Asia Pacific intravenous immunoglobulin market generated a revenue of USD 2,968.8 million in 2023.
  • The market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
  • In terms of segment, immunodeficiency diseases was the largest revenue generating application in 2023.
  • Kawasaki Disease is the most lucrative application segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2024 to 2030.

Asia Pacific data book summary

Market revenue in 2023USD 2,968.8 million
Market revenue in 2030USD 5,201.7 million
Growth rate8.3% (CAGR from 2023 to 2030)
Largest segmentImmunodeficiency diseases
Fastest growing segmentKawasaki Disease
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImmunodeficiency diseases, CIDP, Hypogammaglobulinemia, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome
Key market players worldwideBiotest AG ADR, Baxter International Inc, Grifols SA Ordinary Shares - Class A, CSL Ltd, Octapharma AG, LFB (Laboratoire Français du Fractionnement et des Biotechnologies), Taibang Biological Group, Kedrion Biopharma

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 23.1% of the global intravenous immunoglobulin market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 5,201.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Intravenous Immunoglobulin Market Scope

Intravenous immunoglobulin market segmentation & scope
Immunodeficiency diseases
CIDP
Hypogammaglobulinemia
Congenital AIDS
Chronic Lymphocytic Leukemia
Myasthenia Gravis
Multifocal Motor Neuropathy
ITP
Kawasaki Disease
Guillain-Barre Syndrome
Others
Hospital Pharmacy
Specialty Pharmacy
Others

Intravenous Immunoglobulin Market Companies

Name Profile # Employees HQ Website

Asia Pacific intravenous immunoglobulin market size, by country, 2018-2030 (US$M)

Asia Pacific Intravenous Immunoglobulin Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific intravenous immunoglobulin market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more